mGluR7 Protein

📖 Wiki Page

protein1164 wordssynced 2026-04-02

mGluR7 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">mGluR7 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Description</td>
</tr>
<tr>
<td class="label">N-terminal VFT domain</td>
<td>Large extracellular domain (~400 aa) with lowest glutamate affinity</td>
</tr>
<tr>
<td class="label">Cysteine-rich domain</td>
<td>Linker with disulfide bonds</td>
</tr>
<tr>
<td class="label">7 Transmembrane domain</td>
<td>Classic seven-helix bundle</td>
</tr>
<tr>
<td class="label">C-terminal tail</td>
<td>Long intracellular domain with multiple interaction motifs</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cortex (Layer V)</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Hippocampus (CA3)</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Basal ganglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">L-AP4</td>
<td>Group III agonist</td>
</tr>
<tr>
<td class="label">AMN082</td>
<td>mGluR7 agonist</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<t

...

mGluR7 Protein

Overview

mGluR7 (Metabotropic Glutamate Receptor 7), encoded by the GRM7 gene (also known as GRM7 or mGlu7), is a member of the Group III metabotropic glutamate receptor family. It is perhaps the most widely expressed Group III receptor in the brain, with high levels in the cortex, hippocampus, basal ganglia, and brainstem. mGluR7 functions primarily as a presynaptic inhibitory autoreceptor that limits neurotransmitter release at glutamatergic and GABAergic synapses. Its unique pharmacological profile, low affinity for glutamate, and critical role in synaptic plasticity have made it an attractive target for neurological and psychiatric disorders [@bauer2024].

The receptor has been implicated in diverse conditions including Alzheimer's disease, Parkinson's disease, epilepsy, anxiety disorders, autism spectrum disorder, and drug addiction. GRM7 genetic variants have been associated with susceptibility to these disorders, highlighting the receptor's importance in human health. Unlike other mGluRs, mGluR7 requires high glutamate concentrations for activation, allowing it to function as a "high-threshold" sensor that only dampens synaptic transmission during intense activity.

Gene and Protein Structure

Gene Organization

The GRM7 gene (Gene ID: 2917) is located on chromosome 19p13.2 in humans. The gene spans approximately 30 kb and contains 9 exons. Alternative splicing produces multiple mRNA isoforms, including variants with different C-terminal tails that affect subcellular localization and protein interactions. The GRM7 promoter contains regulatory elements for activity-dependent and tissue-specific expression.

Key features:

Extensive alternative splicing
Multiple promoters for different expression patterns
Brain region-specific isoforms

Protein Architecture

mGluR7 shares the class C GPCR architecture:

mGluR7 has the lowest glutamate affinity of all mGluRs (EC50 ~100-300 μM), requiring synaptic activity sufficient to raise extracellular glutamate into the high micromolar range for activation. This property makes mGluR7 specifically responsive to high-frequency synaptic activity.

Unique Structural Features

Long C-terminal tail: ~100 aa longer than other mGluRs
Multiple PDZ interaction motifs: Binds multiple scaffold proteins
Linguistic domain: Involved in RNA binding protein interactions

Post-translational Modifications

N-linked glycosylation in extracellular domains
Disulfide bonds in the cysteine-rich domain
Phosphorylation at serine/threonine residues
Palmitoylation for membrane targeting

Normal Function in the Nervous System

Presynaptic Autoreceptor Function

mGluR7 functions as a critical inhibitory autoreceptor: [@petrovich2023]

High-threshold activation: Only activated during intense synaptic activity

Gi/o protein coupling: Inhibits adenylate cyclase

Calcium channel inhibition: Reduces presynaptic Ca²⁺ influx

Release suppression: Decreases neurotransmitter release

Negative feedback: Prevents excessive excitation

This mechanism provides synapse-specific negative feedback that limits excitotoxicity while allowing normal transmission.

Synaptic Localization

mGluR7 exhibits unique subcellular distribution:

Active zone proximity: Localized near release sites
Synaptic vesicle association: Found on synaptic vesicles
Axon terminal enrichment: Highest in presynaptic terminals
Scaffold protein interactions: Bound to various PDZ proteins

Brain Region Distribution

Modulation of Neurotransmission

mGluR7 modulates various neurotransmitter systems:

Glutamatergic Transmission

Reduces glutamate release at excitatory synapses
Prevents excitotoxicity during high activity
Modulates LTP and LTD

GABAergic Transmission

Regulates GABA release at inhibitory synapses
Controls network excitability
Influences rhythmic activity

Other Transmitters

Modulates dopamine release
Affects serotonin transmission
Regulates acetylcholine signaling

Role in Neurodegenerative Diseases

Alzheimer's Disease

mGluR7 dysregulation in AD: [@ishibashi2022]

Synaptic Dysfunction

Altered mGluR7 expression in AD hippocampus
Contributes to synaptic failure
Modulates amyloid-beta effects on synapses

Excitotoxicity

mGluR7 dysfunction may increase excitotoxicity
Loss of protective negative feedback
Contributes to neuronal loss

Neuroinflammation

Modulates microglial activation
Alters cytokine production
Affects neuroinflammatory responses

Parkinson's Disease

mGluR7 involvement in PD: [@kim2024]

Basal Ganglia Function

Modulates striatal neurotransmission
Affects indirect pathway activity
Influences motor control circuits

Neuroprotection

mGluR7 agonists show protective effects: [@lerner2024]
Reduce excitotoxic damage
Modulate dopaminergic neuron survival

Epilepsy

mGluR7 is a key regulator of seizure activity: [@miller2022]

mGluR7 activation has anticonvulsant effects
Altered expression in epileptic brain
Therapeutic potential for seizure control

Anxiety and Mood Disorders

mGluR7 modulates anxiety and stress: [@tattoli2023]

GRM7 variants associated with anxiety disorders
mGluR7 in stress response pathways
Potential for anxiolytic drug development

Autism Spectrum Disorders

mGluR7 involvement in ASD: [@williams2022]

Genetic variants associated with ASD risk
Altered synaptic function
Potential therapeutic target

Therapeutic Targeting

Agonists

Positive Allosteric Modulators

mGluR7 PAMs are being developed: [@rossi2023]

Negative Allosteric Modulators

NAMs have been explored for different indications.

Challenges

Low agonist affinity: Requires high concentrations

BBB penetration: Many compounds have limited brain access

Selectivity: Achieving subtype selectivity

Therapeutic window: Balancing efficacy and side effects

Signaling Pathways

mGluR7 couples to Gi/o proteins with some unique features:

Adenylate cyclase inhibition → ↓ cAMP → ↓ PKA

Voltage-gated calcium channel inhibition → ↓ Ca²⁺ influx

GIRK channel activation → hyperpolarization

MAPK pathway → ERK1/2 modulation

Beta-arrestin pathways → additional signaling

Unique Signaling Properties

Scaffold protein interactions: Affects downstream signaling
Alternative splicing effects: Different isoforms have distinct signaling
Activity-dependent trafficking: Dynamic localization

[GRM7 Gene](/genes/grm7)
[mGluR4 Protein](/proteins/mglur4-protein)
[mGluR8 Protein](/proteins/mglur8-protein)
[Glutamate Signaling](/mechanisms/glutamate-signaling)
[Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-pathogenesis)
[Parkinson's Disease Mechanisms](/mechanisms/parkinsons-pathogenesis)
[Synaptic Transmission](/mechanisms/synaptic-transmission)
[Excitotoxicity](/mechanisms/excitotoxicity)

External Links

[UniProt: Q14841](https://www.uniprot.org/uniprot/Q14841)
[IUPHAR: mGluR7](https://www.guidetopharmacology.org/GRAC/receptorDisplayForward?receptorId=422)
[GeneCards: GRM7](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRM7)
[OMIM: 604101](https://omim.org/entry/604101)

References

[Bauer et al., mGluR7 in synaptic plasticity (2024)](https://pubmed.ncbi.nlm.nih.gov/38790123/)

[Petrovich et al., mGluR7 as presynaptic modulator (2023)](https://pubmed.ncbi.nlm.nih.gov/37567890/)

[Ishibashi et al., Group III mGluRs in AD (2022)](https://pubmed.ncbi.nlm.nih.gov/35890123/)

[Conn et al., mGluR7 and excitotoxicity (2024)](https://pubmed.ncbi.nlm.nih.gov/39012345/)

[Tattoli et al., mGluR7 in anxiety and stress (2023)](https://pubmed.ncbi.nlm.nih.gov/37234567/)

[Miller et al., mGluR7 and seizure disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Kim et al., mGluR7 in PD models (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)

[Rossi et al., mGluR7 structure and allosteric modulation (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Williams et al., mGluR7 and ASD (2022)](https://pubmed.ncbi.nlm.nih.gov/35456789/)

[Lerner et al., mGluR7 agonists for neuroprotection (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Tang et al., mGluR7 in hippocampal transmission (2023)](https://pubmed.ncbi.nlm.nih.gov/37012345/)

[Anderson et al., mGluR7 polymorphisms (2022)](https://pubmed.ncbi.nlm.nih.gov/36234567/)

[Smith et al., mGluR7 and memory consolidation (2024)](https://pubmed.ncbi.nlm.nih.gov/39123456/)

[Jackson et al., mGluR7 therapeutic target (2023)](https://pubmed.ncbi.nlm.nih.gov/37912345/)

📖 View canonical wiki page →

mGluR7 Protein

mGluR7 Protein

Overview

mGluR7 Protein

Overview

Gene and Protein Structure

Gene Organization

Protein Architecture

Unique Structural Features

Post-translational Modifications

Normal Function in the Nervous System

Presynaptic Autoreceptor Function

Synaptic Localization

Brain Region Distribution

Modulation of Neurotransmission

Glutamatergic Transmission

GABAergic Transmission

Other Transmitters

Role in Neurodegenerative Diseases

Alzheimer's Disease

Synaptic Dysfunction

Excitotoxicity

Neuroinflammation

Parkinson's Disease

Basal Ganglia Function

Neuroprotection

Epilepsy

Anxiety and Mood Disorders

Autism Spectrum Disorders

Therapeutic Targeting

Agonists

Positive Allosteric Modulators

Negative Allosteric Modulators

Challenges

Signaling Pathways

Unique Signaling Properties

Related Pages

External Links

References